Tisagenlecleucel - The first approved CAR-T-cell therapy: Implications for payers and policy makers

Research output: Contribution to journalComment/debate

51 Scopus citations
Original languageEnglish (US)
Pages (from-to)11-12
Number of pages2
JournalNature Reviews Clinical Oncology
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2018

ASJC Scopus subject areas

  • Oncology

Cite this